203 related articles for article (PubMed ID: 28795988)
1. Eltrombopag to Treat Thrombocytopenia During Last Month of Pregnancy in a Woman With MYH9-Related Disease: A Case Report.
Favier R; De Carne C; Elefant E; Lapusneanu R; Gkalea V; Rigouzzo A
A A Pract; 2018 Jan; 10(1):10-12. PubMed ID: 28795988
[TBL] [Abstract][Full Text] [Related]
2. First successful use of eltrombopag before surgery in a child with MYH9-related thrombocytopenia.
Favier R; Feriel J; Favier M; Denoyelle F; Martignetti JA
Pediatrics; 2013 Sep; 132(3):e793-5. PubMed ID: 23940247
[TBL] [Abstract][Full Text] [Related]
3. Eltrombopag to allow chemotherapy in a patient with MYH9-related inherited thrombocytopenia and pancreatic cancer.
Paciullo F; Bury L; Gresele P
Int J Hematol; 2020 Nov; 112(5):725-727. PubMed ID: 32557126
[TBL] [Abstract][Full Text] [Related]
4. Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure.
Arif AR; Zhao M; Chen W; Xue M; Luo S; Wang Y
Platelets; 2022 Nov; 33(8):1307-1311. PubMed ID: 35791514
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of
Rabbolini DJ; Chun Y; Latimer M; Kunishima S; Fixter K; Valecha B; Tan P; Chew LP; Kile BT; Burt R; Radhakrishnan K; Bird R; Ockelford P; Gabrielli S; Chen Q; Stevenson WS; Ward CM; Morel-Kopp MC
Platelets; 2018 Dec; 29(8):793-800. PubMed ID: 29090586
[No Abstract] [Full Text] [Related]
6. Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations.
Pecci A; Gresele P; Klersy C; Savoia A; Noris P; Fierro T; Bozzi V; Mezzasoma AM; Melazzini F; Balduini CL
Blood; 2010 Dec; 116(26):5832-7. PubMed ID: 20844233
[TBL] [Abstract][Full Text] [Related]
7. Treatment of severe thrombocytopenia associated with systemic lupus erythematosus in pregnancy with eltrombopag: A case report and literature review.
Leng Q; Wang W; Wang Y; Wu L
J Clin Pharm Ther; 2021 Apr; 46(2):532-538. PubMed ID: 33277725
[TBL] [Abstract][Full Text] [Related]
8. Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag.
Scheinberg P; Singulane CC; Barbosa LS; Scheinberg M
Clin Rheumatol; 2014 Sep; 33(9):1347-9. PubMed ID: 24740463
[TBL] [Abstract][Full Text] [Related]
9. Molecule of the month. Eltrombopag.
Drug News Perspect; 2008; 21(6):344. PubMed ID: 18836592
[No Abstract] [Full Text] [Related]
10. Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.
Oliva EN; Alati C; Santini V; Poloni A; Molteni A; Niscola P; Salvi F; Sanpaolo G; Balleari E; Germing U; Fenaux P; Stamatoullas A; Palumbo GA; Salutari P; Impera S; Avanzini P; Cortelezzi A; Liberati AM; Carluccio P; Buccisano F; Voso MT; Mancini S; Kulasekararaj A; Morabito F; Bocchia M; Cufari P; Spiriti MA; Santacaterina I; D'Errigo MG; Bova I; Zini G; Latagliata R
Lancet Haematol; 2017 Mar; 4(3):e127-e136. PubMed ID: 28162984
[TBL] [Abstract][Full Text] [Related]
11. Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients.
Di Buduo CA; Laurent PA; Zaninetti C; Lordier L; Soprano PM; Ntai A; Barozzi S; La Spada A; Biunno I; Raslova H; Bussel JB; Kaplan DL; Balduini CL; Pecci A; Balduini A
Elife; 2021 Jun; 10():. PubMed ID: 34059198
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of severe thrombocytopenia with the use of thrombopoeitin receptor agonist eltrombopag in a patient with chronic myelomonocytic leukemia.
Modi Y; Shaaban H; Gauchan D; Maroules M
J Oncol Pharm Pract; 2015 Feb; 21(1):74-5. PubMed ID: 25063763
[TBL] [Abstract][Full Text] [Related]
13. Eltrombopag in thrombocytopenia.
Lawson A
N Engl J Med; 2008 Mar; 358(10):1072; author reply 1072-3. PubMed ID: 18322290
[No Abstract] [Full Text] [Related]
14. Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome.
Gauchan D; Shaaban H; Gedeon D; Maroules M
Ann Hematol; 2014 Oct; 93(10):1777-8. PubMed ID: 24554304
[No Abstract] [Full Text] [Related]
15. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias.
Balduini CL; Pecci A; Savoia A
Br J Haematol; 2011 Jul; 154(2):161-74. PubMed ID: 21542825
[TBL] [Abstract][Full Text] [Related]
16. Macrothrombocytopenia With Döhle Body-Like Granulocyte Inclusions: A Case Report of May-Hegglin Anomaly in a 33-Year-Old White Woman With an Update on the Molecular Findings of MYH9-Related Disease.
Ruhoy SM; Yates A
Lab Med; 2016 Aug; 47(3):246-50. PubMed ID: 27353381
[TBL] [Abstract][Full Text] [Related]
17. Renal Biopsy-induced Hematoma and Infection in a Patient with Asymptomatic May-Hegglin Anomaly.
Matsumoto T; Yanagihara T; Yoshizaki K; Tsuchiya M; Terasaki M; Nagahama K; Shimizu A; Kunishima S; Maeda M
J Nippon Med Sch; 2021 Dec; 88(6):579-584. PubMed ID: 33692298
[TBL] [Abstract][Full Text] [Related]
18. Usage of eltrombopag for chronic immune thrombocytopenia as a pretreatment for splenectomy.
Uwagawa T; Misawa T; Furukawa K; Ito R; Futagawa Y; Yahagi Y; Aiba K; Yanaga K
Acta Haematol; 2013; 129(1):45-7. PubMed ID: 23128016
[No Abstract] [Full Text] [Related]
19. Eltrombopag reduces bleeding complications and the need of platelet transfusions in cirrhotic thrombocytopenic patients subjected to invasive procedures.
Castelli R; Gidaro A; Lambertenghi Deliliers G
Blood Coagul Fibrinolysis; 2021 Mar; 32(2):163-166. PubMed ID: 33555693
[No Abstract] [Full Text] [Related]
20. Current status of thrombopoietic agents.
Rhodes E; Stasi R
Expert Rev Hematol; 2010 Apr; 3(2):217-25. PubMed ID: 21083464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]